- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04814836
Laser Etching Effect on Application Mode of Universal Adhesive
Clinical Evaluation of Cervical Composite Restorations Placed Using Universal Adhesive in Different Modes and Different Etching Methods
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
- Procédure: Total-etch mode with 35% phosphoric acid (K-ETCHANT) (TE-A group)
- Procédure: Selective-etch mode with 35% phosphoric acid (K-ETCHANT) (SE-A group)
- Procédure: Total-etch mode with Er, Cr: YSGG laser (Waterlase MD) (TE-L group)
- Procédure: Selective-etch mode with Er, Cr: YSGG laser (Waterlase MD) (SE-L group).
- Procédure: Self-etch mode Clearfil Universal Bond Quick (Kuraray, Japan) (SE group)
Description détaillée
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Ankara, Turquie, 06100
- Hacettepe University Faculty of Dentistry
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Participants were 18 years of age or older,
- no possible health problems (such as allergies) related to resin-based restorations,
- good general health,
- having at least five non-carious cervical lesions.
- The depth of the lesions were at least 1 mm, without carious, not previously restored, having teeth with vital, enamel and dentin tissue.
Exclusion Criteria
- Participant had fewer than 20 teeth,
- having poor oral hygiene,
- uncontrolled periodontal disease,
- xerostomia,
- pregnancy or breastfeeding possible health problems (such as allergy) related to resin-based restorations,
- having bleaching treatment or orthodontic treatment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: Group I
Total-etch mode with 35% phosphoric acid
|
35% phosphoric acid was applied to enamel and dentin for 10 s, washed and dried for 5 s.
The universal adhesive, Clearfil Universal Bond Quick (CBQ) was applied to enamel and dentin surfaces with a single-use applicator, then gently air-dried for 5 s without waiting, and light-cured for 10 s.
|
|
Autre: Group II
Selective-etch mode with 35% phosphoric acid
|
35% phosphoric acid was used only on enamel for 10 s, then washed and dried for 5 seconds.
Subsequently, the adhesive was applied in a similar manner to the TE-A group.
|
|
Autre: Group III
Total-etch mode with laser (Er,Cr:YSGG)
|
the enamel margin and dentin surfaces of lesions were irradiated with an Er,Cr:YSGG laser (2780 nm, Waterlase MD, BioLase Technology, Inc., San Clemente, CA).
Then the adhesive was applied in a similar manner to the TE-A group.
|
|
Autre: Group IV
Selective-etch mode with laser (Er,Cr:YSGG)
|
The laser system was applied in the same way as described in the TE-L group only on enamel surface.
Subsequently, the adhesive was applied in the same way as described in the TE-A group.
|
|
Autre: Group V
Self-etch mode
|
Universal adhesive system (CBQ) was applied to enamel and dentin surfaces without any previous etching.
Then gently air-dried for 5 s without waiting, and light-cured for 10 s.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Retention,
Délai: From baseline to 2 year the change of restorations was evaluated
|
The retention criterion determines how long a restorative material functions in the oral environment, it is the most important criterion that shows the success of the material. Alpha: The restoration is present. Charlie: The restoration is absent. |
From baseline to 2 year the change of restorations was evaluated
|
|
Marginal Discoloration
Délai: From baseline to 2 year the change of restorations was evaluated
|
The marginal discoloration that occur at the edge staining restoration boundaries are generally thought to be due to microleakage. Alpha: No discoloration at margins. Bravo: Shallow discoloration, clinically acceptable. Charlie: Deep discoloration clinically unacceptable. |
From baseline to 2 year the change of restorations was evaluated
|
|
Marginal Adaptation
Délai: From baseline to 2 year the change of restorations was evaluated
|
Marginal adaptation is achieved by fully ensuring the integrity of the tooth-restoration joint border. Alpha: Restoration is closely adapted to the tooth. Bravo: Visible evidence of a crevice along the margin, dentin not exposed, clinically acceptable. Charlie: Explorer penetrates into crevice, dentin is exposed; clinically unacceptable. |
From baseline to 2 year the change of restorations was evaluated
|
|
Color match
Délai: From baseline to 2 year the change of restorations was evaluated
|
Color match is the evaluation of the restoration according to the darkening or lightening of the color, taking into account the tooth tissue surrounding restoration. Alpha:Matches tooth. Bravo: Acceptable mismatch. Charlie:Unacceptable mismatch. |
From baseline to 2 year the change of restorations was evaluated
|
|
Post-op Hypersensitivity
Délai: From baseline to 2 year the change of restorations was evaluated
|
Determination of sensitivity after restorations are placed.
Alpha: Absent.
Charlie: Present; clinically unacceptable.
|
From baseline to 2 year the change of restorations was evaluated
|
|
Secondary Caries
Délai: From baseline to 2 year the change of restorations was evaluated
|
Secondary caries is the progression of caries in the tooth tissue adjacent to the restorations. Caries formation means restoration failure. Alpha: Absent. Charlie: Present; clinically unacceptable. |
From baseline to 2 year the change of restorations was evaluated
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: A. Ruya Yazici, Hacettepe University Faculty of Dentistry
Publications et liens utiles
Publications générales
- Atalay C, Uslu A, Yazici AR. Does laser etching have an effect on application mode of a universal adhesive?-A microleakage and scanning electron microscopy evaluation. Microsc Res Tech. 2021 Jan;84(1):125-132. doi: 10.1002/jemt.23573. Epub 2020 Aug 27.
- Atalay C, Ozgunaltay G, Yazici AR. Thirty-six-month clinical evaluation of different adhesive strategies of a universal adhesive. Clin Oral Investig. 2020 Apr;24(4):1569-1578. doi: 10.1007/s00784-019-03052-2. Epub 2019 Aug 30.
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- KA180076
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Participant en bonne santé
-
AstraZenecaParexelComplété
-
PfizerComplété
-
Saglik Bilimleri UniversitesiRecrutementParticipant en bonne santéTurquie
-
Fujian Akeylink Biotechnology Co., Ltd.ComplétéParticipant en bonne santéChine
-
Hacettepe UniversityActif, ne recrute pasParticipant en bonne santéTurquie
-
PfizerRecrutement
-
PfizerActif, ne recrute pasParticipant en bonne santéÉtats-Unis
-
PfizerComplétéParticipant en bonne santéÉtats-Unis
-
Denali Therapeutics Inc.TakedaComplétéParticipant en bonne santéPays-Bas
-
GI Innovation, Inc.GILongevityRecrutementÂgé | Survivants du cancer | Participant en bonne santéAustralie